Lori Eaton
Psychiatric/Mental Health · Manchester, NHNPI 1720331846
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 172 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by AbbVie at 27.9% of the total. Reporting peaked in 2022 at $1,452 and has fallen 70.4% since, to $430 in 2024. Among psychiatric/mental health clinicians in NH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 172 payments — averaging $23.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Vanda Pharmaceuticals Inc.$1K
- Teva Pharmaceuticals USA, Inc.$385
- Neurocrine Biosciences, Inc.$252
- Takeda Pharmaceuticals U.S.A., Inc.$209
- Supernus Pharmaceuticals, Inc.$197
- plus $855 from 9 others
What the payments were for
- Food & beverage$4,116100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 47 | $1,147 |
| Vanda Pharmaceuticals Inc. | 37 | $1,070 |
| Teva Pharmaceuticals USA, Inc. | 24 | $385 |
| Neurocrine Biosciences, Inc. | 6 | $252 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $209 |
| Supernus Pharmaceuticals, Inc. | 11 | $197 |
| Alkermes, Inc. | 6 | $188 |
| Axsome Therapeutics, Inc. | 3 | $179 |
| Lundbeck LLC | 9 | $163 |
| Bausch Health US, LLC | 6 | $102 |
| Otsuka America Pharmaceutical, Inc. | 5 | $94 |
| Corium, LLC | 3 | $65 |
| Sunovion Pharmaceuticals Inc. | 3 | $34 |
| Novo Nordisk | 1 | $17 |
| Ironshore Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,116 in reported general payments places this provider in the 90th percentile of 264 psychiatric/mental health providers in New Hampshire.
See all psychiatric/mental health providers in New Hampshire →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydroxyzine Hcl | 19 | $1,130 |
| Clonazepam | 14 | $131 |
| Diazepam | 12 | $17 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Manchester
- Craig IannottiManchester$146K
- Michael ScottManchester$48K
- Richard WilliamsManchester$5K
- Wendilyn PresleyManchester$4K
- Yu-Mei ChenManchester$3K
- Ry BilladeauManchester$3K
- Oluwatobi OgunbayoManchester$3K
- Kimberly KinneManchester$3K
- Melissa FrenchManchester$2K
- Erika HoodManchester$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.